期刊文献+

系统性硬皮病患者外周血Th17/Treg细胞与病情活动的相关性 被引量:5

Relationships of peripheral blood Thl7 and regulatory T cells with disease activity in patients with systemic sclerosis
原文传递
导出
摘要 目的 探讨系统性硬皮病(SSc)患者外周血Th 17/Treg细胞与病情活动的相关性.方法 45例SSc患者中活动组21例,非活动组24例,正常人对照组24例.用流式细胞仪检测外周血Th17、Treg细胞各占CD4+细胞的百分比.荧光定量PCR法检测外周血单一核细胞(PMBC)中白介素17A(IL-17A)、维A酸类核孤儿受体γ(RoRγt)、叉头状螺旋转录因子3(FoxP3)mRNA水平.酶联免疫吸附试验检测血清IL-17水平.结果 ①SSc活动组、非活动组和正常人对照组外周血Th17细胞占CD4+细胞的百分比分别为2.34±1.19、0.68±0.39和0.57±0.49,活动组显著高于非活动组、正常人对照组(P<0.05).3组外周血Treg细胞比例差异无统计学意义(P>0.05);②SSc活动组、非活动组和正常人对照组外周血IL-17水平分别为53.60±9.90、15.18±3.24、15.53±4.12 pg/ml,对照组和非活动组均显著低于活动组(P<0.05);③SSc活动组、非活动组和对照组3组外周血细胞IL-17A mRNA表达水平分别为11.73±0.80、9.77±1.30、10.79±0.74,活动组显著高于对照组、非活动组(P<0.05);3组外周血细胞中RoRγt mRNA表达水平分别为18.48±1.09、15.89±1.48、17.77±1.64,活动组显著高于对照组和非活动组(P<0.05),3组外周血细胞FoxP3mRNA表达水平差异无统计学意义(P>0.05);④外周血Th17细胞比例、血清IL-17水平与活动组SSc患者的病情活动度呈正相关,分别为r=0.675(P< 0.05)、r=0.644(P< 0.05).结论 Th17细胞亚群在活动期SSc患者体内扩增,其扩增与SSc活动密切相关. Objective To evaluate the relationship of peripheral blood Th17 and regulatory T (Treg) cells with disease activity in patients with systemic sclerosis (SSc).Methods This study recruited 21 patients with active SSc,24 patients with inactive SSc and 24 normal human controls with informed consent.Peripheral blood samples were obtained from these subjects.Flow cytometry was used to detect the percentages of Th17 and Treg cells in peripheral blood CD4+ cells,a fluorescence-based quantitative PCR to determine the levels of interleukin (IL)-17A,retinoid-related orphan receptor gamma t (RoRγt),forkhead box P3 (FoxP3) mRNA in peripheral blood mononuclear cells (PMBCs),and enzyme linked immunosorbent assay to measure the serum level of IL-17.Results Increased percentage of Th17 cells in peripheral blood CD4+ cells was observed in patients with active SSc compared with those with inactive SSc and normal human controls (2.34% ± 1.19%vs.0.68% ± 0.39% and 0.57% ± 0.49%,respectively,both P 〈 0.05).No statistical difference was noted in the percentage of Treg cells in CD4+ cells or the mRNA expression levels of FoxP3 between the patients with active SSc,inactive SSc and normal human controls (all P 〉 0.05).There was a significant increase in the mRNA expression of IL-17A,RoRγt in PBMCs and serum levels of IL-17 in patients with active SSc compared with patients with inactive SSc and normal human controls ( 11.73 ± 0.80 vs.9.77 ± 1.30 and 10.79 ± 0.74,respectively,both P 〈 0.05; 18.48 ± 1.09 vs.15.89 ± 1.48 and 17.77 ± 1.64,respectively,both P 〈 0.05; 53.60± 9.90 pg/ml vs.15.18 ± 3.24 pg/ml and 15.53 ± 4.12 pg/ml,respectively,both P 〈 0.05).The percentage of Th17 cells in CD4+ cells and serum IL-17 levels were both positively correlated with disease activity in patients with active SSc (r =0.675,0.644,respectively,both P 〈 0.05).Conclusions Th17 cells are highly proliferative in patients with active SSc,which may be closely correlated with the activity of SSc.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2012年第1期12-15,共4页 Chinese Journal of Dermatology
基金 基金项目:国家自然科学基金(30872274)
关键词 硬皮病 系统性 TH17细胞 T淋巴细胞 调节性 Scleroderma, systemic Th17 cells T-lymphocytes, regulatory
  • 相关文献

参考文献10

  • 1Yang J,Chu Y,Yang X,et al.Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum,2009,60(5):1472-1483.
  • 2Valentini G,Della Rossa A,Bombardieri S,et al.European multicentre study to define disease activity criteria for systemic sclerosis.Ⅱ.Identification of disease activity variables and development of preliminary activity indexes.Ann Rheum Dis,2001,60(6):592-598.
  • 3Langrish CL,Chen Y,Blumenschein WM,et al.IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.J Exp Med,2005,201 (2):233-240.
  • 4沈斌,冷建杭,王克义,吴黎明,卜璋于,李雅芬,陈健,苏明.慢性特发性荨麻疹患者外周血调节性T细胞和IL-17水平的研究[J].中华皮肤科杂志,2010,43(12):871-872. 被引量:17
  • 5Korn T,Bettelli E,Oukka M,et al.IL-17 and Th17 Cells.Annu Rev Immunol,2009,27:485-517.
  • 6Harrington LE,Hatton RD,Mangan PR,et al.Interleukin 17-producing CD4 + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages.Nat Immunol,2005,6(11):1123-1132.
  • 7Murata M,Fujimoto M,Matsushita T,et al.Clinical association of serum interleukin-17 levels in systemic sclerosis:is systemic sclerosis a Th17 disease? J Dermatol Sci,2008,50(3):240-242.
  • 8Curotto de Lafaille MA,Lafaille JJ.CD4+ regulatory T cells in autoimmunity and allergy.Curr Opin Immunol,2002,14 (6):771-778.
  • 9Slobodin G,Ahmad MS,Rosner I,et al.Regulatory T cells CD4+CD25brightFoxP3 + expansion in systemic sclerosis correlates with disease activity and severity.Cell Immunol,2010,261 (2):77-80.
  • 10Radstake TR,van Bon L,Broen J,et al.Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.PLoS One,2009,4(6):e5981.

二级参考文献8

  • 1Oboki K,Ohno T,Saito H,et al.Th17 and allergy.Allergol Int,2008,57(2):121-134.
  • 2Gri G,Piconese S,Frossi B,et al.CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction.Immunity,2008,29(5):771-781.
  • 3Akdis CA,Akdis M.Mechanisms and treatment of allergic disease in the big picture of regulatory T cells.J Allergy Clin Immunol,2009,123(4):735-746.
  • 4Yang XF.Factors regulating apoptosis and homeostasis of CD4+ CD25 (high) FOXP3+ regulatory T cells are new therapeutic targets.Front Biosci,2008,13:1472-1499.
  • 5Tesmer LA,Lundy SK,Sarkar S,et al.Th17 cells in human disease.Immunol Rev,2008,223:87-113.
  • 6Dos Santos JC,Azor MH,Nojima VY,et al.Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria.Int Immunopharmacol,2008,8(10):1433-1440.
  • 7Chen WC,Chiang BL,Liu HE,et al.Defective functions of circulating CD4+CD25+ and CD4+CD25-T cells in patients with chronic ordinary urticaria.J Dermatol Sci,2008,51(2):121-130.
  • 8伍斌,谢红付,张江林,杜乾君,李吉,谭帅,唐桦.苦参素治疗慢性荨麻疹患者疗效及外周血Foxp3+调节性T细胞的检测[J].中华皮肤科杂志,2009,42(9):635-637. 被引量:3

共引文献16

同被引文献35

  • 1吴长有.Th17细胞:一种新的效应CD4^+T细胞亚群[J].细胞与分子免疫学杂志,2006,22(6):695-697. 被引量:36
  • 2崔盘根,李晶冰,张彩萍,王淼淼,张传福,蒋明军,林麟.阿维A联合血管扩张剂治疗6例系统性硬皮病疗效观察[J].临床皮肤科杂志,2007,36(2):113-114. 被引量:6
  • 3Smolders J,Menheere P,Thewissen M. Regulatory T cell function cor-relates with serum 25-hydroxyvitamin D,but not with 1,25-di-hydroxyvitamin D,parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis[J].The Journal of Steroid Bio-chemistry and Molecular Biology,2010.243-246.
  • 4Heidt S,San D. The impact of Th17 cells on transplant rejection and the induction of tolerance[J].Current Opinion in Organ Transplantation,2010.456-461.
  • 5Luis Mendoza. A robust model to describe the differentiation of T-help-er cells[J].Theory In Biosciences,2011.283-293.
  • 6赵辨.临床皮肤病学[M]南京:江苏科学技术出版社,2001672-679.
  • 7Marcellus DC,Altomonte VL,Farmer ER. Etretinate therapy for refractory sclerodermatous chronic graft-versus-host disease[J].Blood,1999,(01):66-70.
  • 8Takaharu I,Koji U,Fukumi F. The Vitamin A derivative etretinate improves skin sclerosis in patients with systemic sclerosis[J].Journal of Dermatological Science,2004,(01):62-66.
  • 9Toshiyuki Y,Shinsuke T,Ichiro K. Animal model of sclerotic skin.I:Local injections of bleomycin induce sclerotic skin mimicking scleroderma[J].Journal of Investigative Dermatology,1999,(04):456-462.
  • 10Stehlin-Gaon C,Willmann D,Zeyer D. All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta[J].Nature Structural Biology,2003,(10):820-825.doi:10.1038/nsb979.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部